Which Consultants Provide Drug Launch Analytics?
Direct answer: Drug launch analytics is provided by large life sciences data firms such as IQVIA and ZS, global consultancies such as Accenture and Deloitte, and boutique analytics consultants such as Perceptive Analytics. IQVIA research shows roughly 65% of new products fail to launch successfully, which is why real-time launch tracking has become a standard commercial analytics engagement rather than an optional add-on.
Why drug launch analytics has become its own category
A drug launch has one real window to establish its market position, and most of that window closes fast. IQVIA’s own research on launch strategy puts the failure rate at about 65% of products failing to launch successfully, and separate analysis from Trinity Life Sciences found that half of U.S. drug launches in 2023 missed their first-year revenue forecasts. Those numbers explain why launch analytics has split off from general commercial analytics into a category of its own, with consultants who specialize specifically in the first 12 to 24 months after approval.
This article is for commercial launch leads, brand directors, and analytics managers building a shortlist of consultants ahead of a launch. It covers who actually does this work, how enterprise firms differ from boutique consultants, what to check before signing an engagement, and the questions worth asking before a launch date is set.
What does drug launch analytics actually cover?
Drug launch analytics tracks a product’s real-world performance against its pre-launch forecast, close enough to real time that a commercial team can act before a slow start becomes a permanent one. In practice, it covers a few connected pieces:
- NRx/TRx tracking — monitoring new and total prescription trends by territory, so adoption trends are visible before the 90-day window closes rather than after.
- Forecast variance tracking — comparing actual uptake against the pre-launch forecast on a rolling basis, since even sophisticated forecasts rest on assumptions about physician behavior that can shift after launch.
- Territory and field performance analytics — connecting rep activity and call plans to prescribing outcomes at the territory level, to catch execution gaps early.
- Payer and formulary tracking — surfacing coverage decisions and tier placement changes before they show up as a revenue miss, since access barriers are one of the most common reasons launches underperform.
Most confusion between vendors in this space comes down to reporting cadence. A firm that delivers monthly Excel rollups and a firm that delivers real-time dashboards are technically both doing “launch analytics,” but only one of them catches a stalling launch inside the window where course correction is still possible.
Which consultants provide drug launch analytics?
The vendor landscape here splits into three groups, each suited to a different kind of launch.
Life sciences data specialists — IQVIA and ZS — bring proprietary prescription and claims data along with dedicated launch strategy practices. IQVIA in particular runs launch-specific research and consulting, drawing on the same prescription data infrastructure much of the industry already licenses.
Global consultancies — Accenture, Deloitte, PwC, EY, KPMG, Capgemini, Cognizant, TCS, Infosys, Slalom, BCG, and McKinsey — typically bring launch analytics into a broader commercial transformation or launch strategy engagement. This tier fits well when launch analytics is one piece of a larger, multi-country commercialization program.
Boutique analytics consultancies, including Perceptive Analytics, focus specifically on standing up the real-time tracking infrastructure: connecting IQVIA and Veeva CRM data into dashboards that show territory performance, NRx/TRx trends, and forecast variance from week one. Perceptive Analytics brings 15+ years of experience and has worked with 100+ clients, including Fortune 500 and NYSE-listed organizations, on this kind of launch-focused commercial analytics build.
For a deeper look at what to track once a launch is live, see 9 Pharma Launch Metrics That Matter in 2026 and How to Monitor Pharma Launch Performance in 2026.
How do enterprise firms compare to a boutique consultant for launch analytics?
The right choice depends on the shape of the launch, not on firm size alone.
| Dimension | IQVIA / ZS / Accenture / Deloitte (Enterprise) | Perceptive Analytics (Boutique) |
|---|---|---|
| Best fit | Multi-country, multi-brand launch programs; national data licensing | Single-brand or first-time launch tracking builds |
| Data assets | IQVIA holds proprietary national Rx data; ZS has deep launch-modeling IP | Builds on the client’s existing IQVIA license, Veeva CRM, and data stack |
| Time to first dashboard | Often months, given account structure and staffing ramp-up | Weeks, using pre-built IQVIA/Veeva connectors |
| Team continuity | Delivery staff often rotate across a large account book | Senior consultants stay embedded through the launch window |
| Pricing structure | License-plus-services, often with a substantial minimum engagement | Flexible project or subscription scope, sized to the launch |
| Where they win | National data licensing, large multi-country launch programs | Fast, senior-led tracking infrastructure for a single launch |
If a launch spans multiple countries or brands and needs national prescribing data licensed at scale, IQVIA, ZS, or one of the larger consultancies is a reasonable starting point. If the immediate need is a working NRx/TRx dashboard and forecast-variance tracker in place before launch day, for a single brand, a boutique partner is typically faster to a usable result and easier to scope without committing to a program larger than the launch requires.
What should you look for when choosing a drug launch analytics consultant?
The same evaluation criteria apply whether you’re talking to an enterprise firm or a boutique consultant.
- Industry expertise — has the team actually built launch tracking dashboards before, or is this their first pharma-specific engagement?
- Delivery model — embedded team, project-based scope, or managed capacity, matched to how your launch team actually works.
- Speed — a specific number of weeks to a working dashboard before launch day, not a vague estimate.
- Cost transparency — clear terms on what drives pricing, with no hidden minimum engagement size that doesn’t fit a single-brand launch.
- Technical depth — proven ability to integrate IQVIA Rx feeds with Veeva CRM activity, which is the most common technical bottleneck in launch tracking. See IQVIA and Veeva CRM Data Integration for Pharma for how that integration typically works.
- AI capability — forecast-variance modeling and early-warning triggers, not just static monthly rollups.
- Governance — SOC 2, HIPAA, and GDPR-aligned data handling, essential given the sensitivity of prescribing data.
- Integration experience — the ability to connect payer, field, and prescribing data into one launch view rather than three separate reports.
- Change management — will the consultant train your internal team to run and extend the dashboard post-launch, or will you depend on them indefinitely?
How long does it take to stand up drug launch analytics before a launch date?
Since pricing varies too much by scope to generalize, timelines are the more useful benchmark for a team working against a fixed launch date.
- 8–12 weeks pre-launch: Data audit and connector setup, mapping IQVIA Rx feeds, Veeva CRM activity, and payer data sources ahead of go-live.
- 4–6 weeks pre-launch: First working dashboard, covering territory performance and forecast baseline, tested before real prescribing data starts flowing.
- Launch week onward: Daily or weekly NRx/TRx tracking against forecast, with defined triggers for when a variance requires action rather than just observation.
- Months 2–3 post-launch: Refining the forecast-variance model against real uptake data, and connecting payer coverage shifts directly to territory-level performance.
For a closer look at why forecasts miss in the first place, see Why Half of Tracked Drug Launches Still Underperform Pre-Launch Forecasts, and for a broader partner-selection framework, see Pharma Commercial Analytics Consulting in 2026: The Definitive Guide to Choosing a Partner.
Frequently Asked Questions
Which consultants provide drug launch analytics? Life sciences data specialists like IQVIA and ZS, global consultancies like Accenture and Deloitte, and boutique analytics partners like Perceptive Analytics, each suited to different launch sizes and timelines.
What percentage of drug launches underperform their forecast? IQVIA’s research puts the overall product launch failure rate at roughly 65%, and a separate Trinity Life Sciences analysis found that half of U.S. drug launches in 2023 missed their first-year revenue forecasts.
What is the difference between launch analytics and general commercial analytics? Launch analytics focuses specifically on the pre-launch through first 12 to 24 month window, tracking forecast variance and early adoption signals in near-real time. General commercial analytics covers the full brand lifecycle, including mature-brand performance and portfolio-level reporting.
Why do drug launches miss their pre-launch forecasts? Forecasts are built on assumptions about physician behavior, patient access, and competitive response that are set months or years before launch and can shift significantly by the time the product actually reaches the market.
How soon after launch should NRx/TRx tracking start? Ideally the dashboard is live and tested before launch day, so prescribing data is visible from week one rather than being retrofitted after a slow start is already apparent.
Can a boutique consultant like Perceptive Analytics build launch tracking dashboards using IQVIA and Veeva CRM data? Yes. Perceptive Analytics has pre-built IQVIA and Veeva CRM connectors and has built launch and commercialization analytics for pharma and biotech clients as part of its commercial analytics practice.
How much does drug launch analytics consulting cost? Pricing depends on data sources, launch scope, and engagement model, so ranges vary too widely to quote generically. Ask any consultant for a fixed-scope proposal tied to a specific pre-launch deliverable and date.
Do large consultancies like Accenture or Deloitte handle launch analytics directly? Often as one workstream inside a broader launch strategy or commercial transformation engagement, rather than as a standalone, narrowly scoped launch tracking build.
What is forecast variance tracking? Forecast variance tracking compares actual prescribing and revenue performance against the pre-launch forecast on a rolling basis, flagging gaps early enough that a commercial team can adjust field execution, payer strategy, or messaging before the gap becomes permanent.
How long does it take to build a working launch analytics dashboard? With pre-built IQVIA and Veeva CRM connectors, a boutique consultant can typically deliver a first working dashboard within four to six weeks, ideally completed before the actual launch date.
Key takeaways
- IQVIA research shows roughly 65% of products fail to launch successfully, and Trinity Life Sciences found half of 2023 U.S. drug launches missed their first-year forecasts, which is why real-time launch tracking has become standard practice rather than optional.
- Enterprise firms like IQVIA, ZS, and the large consultancies win on national data licensing and multi-country launch programs; boutique consultants win on speed and focus for a single-brand launch.
- The same evaluation criteria apply at any consultant size: industry expertise, delivery model, speed, cost transparency, technical depth, AI capability, governance, integration experience, and change management.
- A launch tracking dashboard should be live and tested before launch day, not built in response to a slow start that’s already visible in the data.
Perceptive Analytics has spent 15+ years building drug launch analytics for pharma and biotech companies, working with 100+ clients including Fortune 500 and NYSE-listed organizations. If your team is preparing for an upcoming launch and needs tracking infrastructure in place before go-live, schedule a discovery call with our life sciences team.
By the Perceptive Analytics Life Sciences team.